These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2743473)

  • 1. Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics.
    Lewis DF; Ioannides C; Parke DV
    Chem Biol Interact; 1989; 70(3-4):263-80. PubMed ID: 2743473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of carcinogens and toxic chemicals.
    Parke DV; Ioannides C; Lewis DF
    Hum Toxicol; 1988 Sep; 7(5):397-404. PubMed ID: 3192223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of chemical carcinogenicity from molecular and electronic structures: a comparison of MINDO/3 and CNDO/2 molecular orbital methods.
    Lewis DF; Ioannides C; Parke DV
    Toxicol Lett; 1989 Jan; 45(1):1-13. PubMed ID: 2644723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation mechanisms to chemical toxicity.
    Parke DV
    Arch Toxicol; 1987; 60(1-3):5-15. PubMed ID: 3304217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dimensions of the substrate binding site of cytochrome P-448.
    Lewis DF; Ioannides C; Parke DV
    Biochem Pharmacol; 1986 Jul; 35(13):2179-85. PubMed ID: 3729975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for substrates of cytochromes P-450 and P-448.
    Lewis DF; Ioannides C; Parke DV
    Chem Biol Interact; 1987; 64(1-2):39-60. PubMed ID: 3690723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between site specificity and electrophilic frontier values in the metabolic hydroxylation of biphenyl, di-aromatic and CYP2D6 substrates: a molecular modelling study.
    Ackland MJ
    Xenobiotica; 1993 Oct; 23(10):1135-44. PubMed ID: 8259695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast prediction of cytochrome P450 mediated drug metabolism.
    Rydberg P; Vasanthanathan P; Oostenbrink C; Olsen L
    ChemMedChem; 2009 Dec; 4(12):2070-9. PubMed ID: 19852016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the substrate-binding sites of liver microsomal cytochrome P-448.
    Phillipson CE; Ioannides C; Delaforge M; Parke DV
    Biochem J; 1982 Oct; 207(1):51-6. PubMed ID: 7181861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms in the activation of nitrogenous compounds by mammalian cytochrome P-450 isozymes.
    Hlavica P
    Drug Metab Rev; 1994; 26(1-2):325-48. PubMed ID: 8082573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cytochrome P-450 catalysis.
    Guengerich FP; MacDonald TL
    FASEB J; 1990 May; 4(8):2453-9. PubMed ID: 2185971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen as Acceptor.
    Borisov VB; Verkhovsky MI
    EcoSal Plus; 2015; 6(2):. PubMed ID: 26734697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant monooxygenases: participation in xenobiotic oxidation.
    Khatisashvili G; Gordeziani M; Kvesitadze G; Korte F
    Ecotoxicol Environ Saf; 1997 Mar; 36(2):118-22. PubMed ID: 9126428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fallacy of using adrenochrome reaction for measurement of reactive oxygen species formed during cytochrome p450-mediated metabolism of xenobiotics.
    Chen C; Thakker DR
    J Pharmacol Exp Ther; 2002 Feb; 300(2):417-20. PubMed ID: 11805199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome b5 as electron donor for oxy-cytochrome P-450.
    Noshiro M; Ullrich V; Omura T
    Eur J Biochem; 1981 Jun; 116(3):521-6. PubMed ID: 7262071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism by cytochrome p450 enzymes: what distinguishes the pathways leading to substrate hydroxylation over desaturation?
    Ji L; Faponle AS; Quesne MG; Sainna MA; Zhang J; Franke A; Kumar D; van Eldik R; Liu W; de Visser SP
    Chemistry; 2015 Jun; 21(25):9083-92. PubMed ID: 25924594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of halogenated alkanes by cytochrome P450 enzymes. Aerobic oxidation versus anaerobic reduction.
    Ji L; Zhang J; Liu W; de Visser SP
    Chem Asian J; 2014 Apr; 9(4):1175-82. PubMed ID: 24501011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.